pRRL WS1.6 WASp Citations (1)

Originally described in: Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich Syndrome.
Astrakhan A, Sather BD, Ryu BY, Khim S, Singh S, Humblet-Baron S, Ochs HD, Miao CH, Rawlings DJ Blood. 2012 Mar 19. PubMed Journal

---

Articles Citing pRRL WS1.6 WASp

Articles
Gene editing-based targeted integration for correction of Wiskott-Aldrich syndrome. Pille M, Avila JM, Park SH, Le CQ, Xue H, Haerynck F, Saxena L, Lee C, Shpall EJ, Bao G, Vandekerckhove B, Davis BR. Mol Ther Methods Clin Dev. 2024 Feb 6;32(1):101208. doi: 10.1016/j.omtm.2024.101208. eCollection 2024 Mar 14. PubMed

If you have published an article using this material, please email us at to have your article added to this page.